This metabolic condition is why stress management and sleep quality matter as much as diet and exercise in weight loss programs
A synthetic version was created in the years after, but it took until 2005 for this GLP-1 agonist to become an FDA-approved treatment for type 2 diabetes
Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives
7 Similarly, a joint guideline by the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) recommends GLP-1RAs as second- or third-line therapy in patients with predominantly atherosclerotic cardiovascular disease, a compelling need to minimise hypoglycaemia or a need to promote weight loss
(3) Ct I, Sakarya Y, Kirichenko N, Morgan D, Carter CS, Tmer N, Scarpace PJ
& Doraiswamy, P